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Here we elaborated an analytical approach for the simulation of dose–response curves mediated by cellular receptors coupled to PLC and Ca2+
mobilization. Based on a mathematical model of purinergic Ca2+ signaling in taste cells, the analysis of taste cells responsiveness to nucleotides
was carried out. Consistently with the expression of P2Y2 and P2Y4 receptors in taste cells, saturating ATP and UTP equipotently mobilized
intracellular Ca2+. Cellular responses versus concentration of BzATP, a P2Y2 agonist and a P2Y4 antagonist, implicated high and low affinity
BzATP receptors. Suramin modified the BzATP dose–response curve in a manner that suggested the low affinity receptor to be weakly sensitive to
this P2Yantagonist. Given that solely P2Y2 and P2Y11 are BzATP receptors, their high sensitivity to suramin is poorly consistent with the suramin
effects on BzATP responses. We simulated a variety of dose–response curves for different P2Y receptor sets and found that the appropriate fit of
the overall pharmacological data was achievable only with dimeric receptors modeled as P2Y2/P2Y4 homo- and heterodimers. Our computations
and analytical analysis of experimental dose–response curves raise the possibility that ATP responsiveness of mouse taste cells is mediated by
P2Y2 and P2Y4 receptors operative mostly in the dimeric form.
© 2007 Elsevier B.V. All rights reserved.Keywords: P2Y receptor; Intracellular Ca2+; Mathematical model; Taste cell1. Introduction
Current knowledge on molecular properties of most
receptors and their coupling to certain signaling cascades is
greatly based on heterologous expression of receptors followed
by studies of cellular responses [1–3]. Although it is a very
effective approach, an expression system is typically a line of
transformed cells with relatively simple physiology compared to
much more complicated natural systems. In different cells, a
given protein (ion channel, receptor) may operate in a quite
different manner, depending on cell-specific microenvironment,
associated accessory proteins, and regulatory cascades. In
addition, multiple receptor isoforms typically operate in native
cells. Therefore, the analysis of agonist–receptor binding and
downstream signaling in natural cells is a complicated matter.
Recently, we have found that extracellular ATP mobilizes
Ca2+ in the taste cell cytoplasm. Evidence implicates P2Y
receptors coupled to the phosphoinositide cascade (receptor–G-⁎ Corresponding author. Tel.: +7 496 773 9121; fax: +7 496 733 0509.
E-mail address: staskolesnikov@yahoo.com (S.S. Kolesnikov).
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doi:10.1016/j.bbamem.2007.04.002protein–phospholipase C (PLC)–IP3 production) in mediating
ATP responses, while a contribution of P2X receptors is neg-
ligible [4,5]. Consistently, the presence of certain P2Y isoforms,
P2Y1, P2Y2, P2Y4, and P2Y6, in the taste tissue has been
demonstrated with the RT-PCR approach [6,7]. These findings
suggest that in taste cells, several P2Y receptor units may me-
diate ATP responses.
The number and type of molecular receptors and their affinity
to an agonist cannot be estimated directly from physiological
data because cellular responses and binding events are coupled
by nonlinear transduction machinery. Particularly, the number of
cascades involved in intracellular signaling can determine the
apparent cooperativity and half-effect concentration character-
istic of a dose–response curve (e.g. [8]). Mathematical models of
intracellular signaling may provide a link between microscopic
parameters of receptor–agonist binding and macroscopic dose–
response curves obtained experimentally.
To characterize P2Y receptors involved, we elaborated a
mathematical model of ATP-dependent Ca2+ signaling in taste
cells. Based on this model and using a number of simplifying
assumptions, we derived analytical expressions that allowed us
to calculate the magnitude of Ca2+ transients as a function of
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analyzed experimental dose–response dependencies for certain
P2Yagonists and antagonists by using both their fit with logistic
equations and computer simulations of dose–response curves to
elucidate a minimal P2Y receptor set necessary for the correct
reproduction of the experimental data.
2. Materials and methods
2.1. Taste bud and cell isolation
Taste buds and cells were isolated as described previously [5] from mouse
circumvallate (CV) papilla. Briefly, mice (6–8 weeks old) were anesthetized
with CO2 gas and killed by upper cervical dislocation, and tongues were
removed. To allow peeling of lingual epithelia, tongues were injected between
the epithelium and muscle layers with the enzyme mixture containing 1 mg/ml
collagenase B, 1 mg/ml dispase II, and 0.2 mg/ml elastase (all from Roche
Diagnostics, Indianapolis, IN), and 0.5 mg/ml trypsin inhibitor (Sigma-Aldrich,
St. Louis, MO) dissolved in a solution (in mM): 140 NaCl, 5 KCl, 0.3 MgCl2,
0.3 CaCl2, 10 HEPES–NaOH (pH 7.4), 10 glucose. The tongue was incubated
in a Ca2+-free solution (140 NaCl, 5 KCl, 1 MgCl2, 1 EGTA, 0.5 EDTA, 10
HEPES–NaOH (pH 7.4), 10 glucose) for 30–35 min. Peeled epithelia were
pinned serosal side up in a dish covered with Sylgard resin and incubated in the
Ca2+-free solution for 10–30 min and thereafter it was stored in a bath solution
(in mM): 135 NaCl, 5 NaHCO3, 5 KCl, 1 MgCl2, 1 CaCl2, 10 HEPES–NaOH
(pH 7.4), 10 glucose. Taste buds and cells were removed from the circumvalate
and foliate papillae by suction with a glass micropipette and then expelled onto a
coverslip for photometry.
2.2. Photometry
Isolated taste buds and individual taste cells were plated onto a coverslip
coated with Cell-Tak (BD Biosciences, Bedford, MA) inside an attached
ellipsoidal resin chamber of 150 μl volume. Taste buds were loaded in the bath
solution containing 5 μM fura-2 AM+0.02% pluronic (all from Molecular
Probes, Eugene, OR) for 40min. The buds (cells) werewashed out twice and then
incubated in the dye-free bath solution for 30 min for complete de-esterification
of the loaded dye. Fluorescence of fura-2-loaded cells was recorded at 510 nm
using an inverted fluorescent microscope Axiovert 100S (Zeiss, Germany)
equipped with a Fluar 40X objective (NA=0.95) and a microscope ratio
photometry system (RM-D model, Photon Technology International, South
Brunswick, NJ) operating in the photon counting mode. By using a variable
diaphragm, an optical signal from a cell group or an individual cell was collected
[5]. All chemicals were bath-applied using a perfusion system driven by gravity,
which allowed for their addition and washout within 3 s Suramin was from
Calbiochem (La Jolla, CA); ATP, ADP, UTP, UDP, 2′,3′-O-(4-benzoylbenzoyl)
ATP (BzATP), and buffers and salts were from Sigma-Aldrich. Given that the
physiological activity of the nucleotides and suramin decreased significantly
within few hours, their solutions were prepared immediately before use.
Experiments were carried out at room temperature of 22–25 °C under red light
illumination.
2.2.1. Suramin inhibition
The P2Y antagonist suramin may exert non-specific effects, including the
direct modulation of receptor–G-protein coupling [9]. To avoid possible artifacts,
we examined the pharmacological activity of suramin solely within the 0.1–
300 μM range. At higher concentrations, it affected resting Ca2+ in taste cells,
presumably via mechanisms not related to the P2Y inhibition. Typically, suramin
was added to the bath ∼1 min prior to P2Y agonist application.
2.3. Computations and data analysis
Equations were solved using the Mathcad software (Mathsoft Engineering
and Education Inc, Cambridge, MA). Curves were fitted with the Marquardt–
Levenberg nonlinear least squares algorithm (SigmaPlot, SPSS, Chicago, IL).
Experimental 340/380 nm ratios were converted into Ca2+ concentrations usingthe apparent Kd=224 nM for Ca
2+-fura-2 binding and the equation originally
introduced by Grynkiewicz and co-authors [10].
2.3.1. Dose–response curves
Although the effects of the P2Y antagonists and BzATP were reported as
reversible, in fact, they reversed completely only after a long washing period
(≥1 h) [11]. Hence, the reversibility of action of these compounds might not be
achievable within the characteristic time (∼40 min) of our stable recordings. For
this reason, solely taste cells with invariable responsiveness were suitable for
examining effects of P2Yagonists and antagonists. However, even if consequent
stimuli were applied at intervals exceeding the refractory period (∼600 s, [5]),
many cells exhibited gradually decreasing ATP responsiveness. We have
established correlations that enabled us to identify cells whose responses were
most likely reproducible in series. Particularly, we found that if the two first
responses to 10 μM ATP were virtually identical (R21= (second response
magnitude)/(first response magnitude)N0.93), a cell generated the similar
response to the third ATP application with the probability of 0.94. Based on
these findings, we recorded two first responses in control, and if R21N0.93, a
cell was then incubated with a P2Yantagonist prior to the third ATP application.
Antagonist effects were assessed quantitatively by the ratio of the third and the
second responses. The relative responsiveness to P2Y agonists was studied in a
similar manner.3. Results
3.1. Model of P2Y-Ca2+ peak coupling
To analyze P2Y-mediated Ca2+ signaling in taste cells at the
receptor level, we elaborated an analytical approach that allowed
for simulating dose–response curves for P2Y agonist/antago-
nists. The signaling cascade (P2Y receptor–G-protein–phos-
pholipase C (PLC)–IP3 production–Ca
2+ mobilization) was not
analyzed as a dynamic system (e.g. [12]), we utilized instead the
steady-state kinetics approach requiring just over half the
number of parameters for computations. Particularly, we took
into account that an individual receptor can activate G-proteins
with subsecond kinetics [13], while ATP mobilizes intracellular
Ca2+ within 3–5 s (see below Fig. 3). It is therefore very likely
that IP3 production and Ca
2+ release rate-limit the Ca2+
signaling initiated by P2Y-ATP binding, thus allowing one to
postulate that all activated species in the P2Y-G-protein-PLC
sequence reach virtual equilibrium before Ca2+ peaks. This
assumption and that d[Ca2+]/dt=0 for the Ca2+ transient
maximum provide rationale for the steady-state approximation.
Based on a fewmore simplifications (see Appendix), we derived
the following system of algebraic equations for the dimension-
less variables x= [Ca2+]p/[Ca
2+]r and y= [IP3]p/[IP3]0.5 to
determine Ca2+ and IP3 concentrations at the moment when
Ca2+ peaks:
g1 þ g2 g3  xð Þ g4 þ
ynxHa
ð1þ ynÞðqHa þ xHaÞ
 
¼ x
m
km þ xm
y ¼ Aþ m x
g1 þ x
þ uFG x
g2 þ x
ð1Þ
where [Ca
2+
]r and [IP3]0.5 are the resting intracellular Ca
2+
concentration and the half-response IP3 concentration for IP3
receptors, FG is the fraction of activated G-proteins; the other
parameters are determined in Appendix A, Eqs. (A15). The
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the expression R=[Ca2+]r(xp−1), where xp is the root of Eq. (1).
The analytical structure of Eq. (1) indicates that kinetic
properties of the signaling sequence agonist–P2Y binding–G-
protein activation influence a model response as much as they
determine the fraction of activated G-proteins. This allows for
modeling different binding events at universal G-protein–Ca2+
response coupling.
3.1.1. Agonist binding and G-protein activation
Given that the inverse agonism has not been reported, to our
knowledge, for P2Y receptors, their constitutive activity can be
postulated as negligible. We therefore posited the following
kinetic scheme to describe the agonist–receptor binding
followed by activation of G-proteins and their inactivation due
to GTP hydrolysis: A+R⇔AR*, AR* +G⇔AR*G⇒AR*+
G*, and G*⇒G, where R, AR*, G, and G* denote non-active
and activated receptors, and non-active and activated G-proteins,
respectively. The fractions of monomeric receptors that are
bound to an agonist A in the presence of a competitive antagonist
I can be written at equilibrium as:
FR ¼ ½AR*=½RT ¼ ð½A=KÞ=ð1þ ½I =Ki þ ½A=KÞ ð2Þ
where [RT] and [AR*] are the total concentration of receptors and
the concentration of receptors bound to agonist molecules, i.e.
activated; [A] and [I] — agonist and antagonist concentrations;
K and Ki — dissociation constants for agonist and antagonist
binding. Because [G*]= [G][AR*]/KG, where the apparent
dissociation constant KG is a combination of the rate constants,
the fraction of G* species in the steady-state is:
FG ¼ ½G*=½GT ¼ ð½AR*=KGÞ=ð1þ ½AR*=KGÞ
¼ dFR=ð1þ dFRÞ ð3Þ
where GT is the total G-protein concentration and δ=[RT]/ KG.
The above kinetic diagram is a simplified approximation of
agonist–receptor–G-protein binding events underlying down-
stream intracellular signaling. However, at virtual equilibrium
and G protein excess (i.e. [GT]≫ [AR*]) and with negligible
constitutive receptor activity, a variety of models, including the
CTC model [14], predicts that the concentration of the ternary
complex AR*G, and thereby the fraction of activated G
proteins, follows a simple Langmuir curves with a Hill slope
of one [15–17]. Therefore, this steady-state approximation may
be valid for much more complex kinetic pathways that link the
activation of G-protein coupled receptors to the relatively slow
PLC-mediated Ca2+ signaling.3.1.2. Ca2+ response simulations
We first examined the capability of our approach to reproduce
such general phenomena as the partial agonism and antagonism
and to simulate dose–response dependencies reminiscent of
those previously reported for recombinant P2Y receptors (e.g.
[11]). The coupling of P2Y receptors to Ca2+ transients was
simulated using Eqs. (1)–(3). A number of model parameters
was fixed over computations based on literature and our own
data, e.g. [Ca2+]r=70 nM, as described below.With receptors of a single type, we examined the sensitivity of
model responses to parameter values and determined the
parameter region where monotonic dose–response curves with
saturation could be generated in the whole range (10−2–103 μM)
of agonist concentrations. It was particularly found that the
model parameters associated with Ca2+ homeostasis (e.g. η1–η4
in Eq. (1)) or IP3 production (μ, ν, θ, and γ in Eq. (1)) markedly
influenced the saturated Ca2+ response but weakly or negligibly
the half-effect concentration EC50 and a shape of simulated
dose–response curves (Fig. 1A–F). Particularly, EC50 of 3.04,
3.05, and 3.01 μM were obtained at η1= 0.00001, 0.0001,
and 0.005, respectively, for the dose–response curves presented
in Fig. 1A, Not surprisingly, EC50 was strongly sensitive to
receptor affinity characterized by the dissociation constant K in
Eq. (2). For example, with K=1, 10, and 100 μM and the other
parameters being invariable, the corresponding dose–response
curves exhibited the same maximal response and proportionally
increased EC50 of 0.21, 2.1, and 20 μM, respectively (Fig. 2A).
The fruitful concept plausibly accounting for the full, partial,
and inverse agonism is that ligand binding induces occupancy
redistribution in the receptor conformational space and stabilizes
a certain receptor conformation(s) that may mediate the stim-
ulation of G-proteins with the maximal, moderate, or negligible
efficacy [18]. Particularly, a partial agonist elicits a smaller
cellular response than a full agonist, at saturating concentrations,
because the former stabilizes a receptor in a less effective active
state. In our model, the efficacy of coupling of agonist binding to
G-protein activation is quantitatively characterized by the
parameter δ in Eq. (3), and as computations showed, both the
maximal response and EC50 were markedly dependent on δ
value. For instance, with K=15 μM, the reduction of δ from 20
to 2 led to the twofold decrease in the maximal response and
increased the EC50 value from 0.22 μM to 9.8 μM (Fig. 2B).
Thus, the partial agonism, which is inherent in our model (Eqs.
(1)–(3)), can quantitatively be reproduced by changing the
model parameter δ, that is, by ascribing different coupling
efficacies to an agonist–receptor complex.
For P2Y2 or P2Y4 receptors heterologously expressed in
oocytes, P2Y-related cellular responses plotted versus nucleo-
tide concentration in the Hill coordinates exhibited slopes of
0.9–1.3, depending on an agonist type [11]. We also ap-
proximated simulated dose–response curves with the Hill
equation R/Rmax=1/(1+(K0.5/[A])
n), where Rmax, K0.5, and n
are the saturated response, half-effect concentration, and Hill
exponent, respectively. At different K and δ and with the other
parameters being as in Fig. 1 legend, theoretical dose–response
curves exhibited the Hill exponent of 1.05–1.1 for monomeric
receptors (e.g. Fig. 2C, open circles). An effect of an antagonist
was simulated by taking nonzero Ki in Eq. (2) and varying [I].
Expectedly for a competitive inhibitor and consistently with
experimental findings [11], theoretical dose–response curves
were simply shifted rightward in the presence of the antagonist,
neither the maximal response nor the Hill exponent (Fig.
2C, filled circles) were altered relative to control (Fig. 2C,
open circles). Theoretical response R(I) versus antagonist
concentration [I] (Fig. 2D, filled circles) normalized to the
control response R0 was well fittable with the Hill equation
Fig. 1. Cellular responses simulated with single type P2Y receptors and variable parameters. (A–C) Dependence of dose–response curves on model parameters η1, η3,
and η4 characterizing Ca
2+ extrusion, Ca2+ buffer capacity, and Ca2+ permeability of reticular membrane, respectively. In panel A, for the curves simulated at
η1 =0.00001, 0.0001, and 0.005, the saturated Ca
2+ response Rmax=278, 230, and 78 nM and EC50=3.04, 3.05, and 3.01 μM, respectively. EC50 values obtained for
curves in panels B–F were also of about 3 μM. (D–E) response magnitudes at varied θ, μ, and γ1 characterizing Ca
2+-dependent IP3 production. In panels A–F,
K=15 μM, δ=10; η1=0.0001, η2=0.114, η4=100, η4=0.00011, ρ=0.38, λ=10, n=2, m=2, Ha=1.8; θ=0.2, μ=0.015, ν=0.1, and γ1=7.1, γ2=5.7, except
when the particular parameter was varied as indicated.
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n) (Fig. 2D, circles) with the exponent
of about 1. For comparison, the similar fit of experimental
inhibitory curves obtained for suramin and some other P2Y
antagonists yielded Hill exponents of 0.9–1.3 [11] (Table 1).
Growing evidence indicates that G-protein-coupled recep-
tors, which were considered as monomeric species for long time,
are subjected to homo- and heterodimerization [19,20].
Particularly, the homodimerization of the P2Y2 receptors [21],
heterodimerization of P2Y1 and A1 adenosine receptors [22],
and oligomerization of P2Y12 receptors [23] have been
documented. We therefore simulated dose–response curves for
dimerized P2Y receptors by substituting Eq. (2) for the
following equation, suggesting that the binding of two agonist
molecules is necessary to render a dimeric receptor active:
FR ¼ ð½A=KÞ2=ð1þ ½I =K þ ½A=KÞ2 ð4Þ
With dimers, we obtained results that were qualitatively
similar to those described for monomeric receptors (Figs. 1 and
2A–D). However, higher apparent cooperativity was character-
istic of cellular responses mediated by dimeric receptors:
response magnitude versus agonist concentration showed the
Hill exponent of about 1.6 (Fig. 2E, circles), whereas
antagonist concentration–inhibition curves yielded 1.4 (Fig.
2F, circles).
Thus, the above computations indicate that our model re-
produces qualitatively and quantitatively well experimentalfindings at least in terms of dose–response curves observed for
recombinant P2Y receptors. This argues that Eq. (1) approx-
imate correctly the coupling of agonist/antagonist-P2Y binding
to Ca2+ transients. We further applied this approach for the
analysis of taste cell responsiveness to ATP and some other P2Y-
related compounds. The necessary experimental facts are de-
scribed below.
3.2. Taste cell responses
In the P2Y family, ADP is a full agonist for P2Y1, P2Y12, and
P2Y13, P2Y6 is a UDP receptor, P2Y11 prefers ATP as an
agonist, while rodent P2Y2 and P2Y4 are equally sensitive to
ATP and UTP [24–26]. In taste cells, a number of P2Yagonists
mobilized intracellular Ca2+, including ATP, UTP, and BzATP,
which showed apparently equal potencies at saturating con-
centrations, and much less potent ADP and UDP (Fig. 3). Such a
broad set of effective P2Y agonists argued that predominantly
P2Y receptors mediate taste cell responsiveness to the nucleo-
tides. Indeed, control experiments have revealed a negligible
contribution of P2X receptors to Ca2+ responses to ATP [4,5].
Consistently, taste cells have been shown to express P2Y1,
P2Y2, P2Y4, and P2Y6 isoforms [7]. Taste cells generate
responses to ADP and UDP most likely by using P2Y1 and
P2Y6, respectively (Fig. 3A), while ATP transduction may
potentially involve three nucleotide receptors, namely, P2Y2,
P2Y4, and P2Y1, The last can be stimulated by ATP either as a
Fig. 2. Simulated dose–response and inhibition curves at different parameters. (A) Cellular responses simulated with variable dissociation constant for agonist–
receptor binding. (B) Dose–response curves calculated with variable parameter δ, that is, with different efficacies of receptor–G-protein coupling. C, E, Ca2+ response
versus agonist concentration simulated for monomeric (C) and dimeric (E) receptors in control (ο) and in the presence of 10 μM antagonist (●). The theoretical
dependencies were fitted with the equation R/Rmax=1/(1+(K0.5/[A])
n) with Rmax=375 nM (continuous curves), yielding the following parameters: in panel C, n=1.09,
K0.5=0.98 μM in control; n=1.09, K0.5=11 μM in the presence of antagonist; in panel E, n=1.6, K0.5=3.9 μM in control; n=1.6, K0.5=65 μM in the presence of
antagonist. (D, F) Inhibitory curves (●) calculated with Ki =2 μM for monomeric (D) and dimeric (F) receptors (Eqs. (2) (4)) stimulated by 10 μM and 25 μM agonist,
respectively. The simulated dependencies were fitted with the equation R(I)/R0=1/(1+([I] /Ki0.5)
n) (continuous curves), where R(I) and R0 are Ca
2+ responses in the
presence and in the absence of antagonist, respectively. In (D), n=1.05, Ki0.5=8 μM. In panel F, n=1.4, Ki0.5=4.1 μM. In all cases, the curves were calculated with the
other model parameters as in Fig. 1 legend.
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ADP by extracellular ectonucleotidases [28]. Note that P2Y1 is
not stimulated by UTP, BzATP is an antagonist for P2Y1 and
P2Y4, [29,30,] and full agonist for P2Y2 [11]. Therefore, UTP
responsiveness can be mediated by P2Y2 and P2Y4 receptors,
while BzATP can stimulate solely P2Y2. Thus, even if each
nucleotide-responsive taste cell expresses the whole set of P2Y
receptors, i.e. P2Y1–P2Y6, to monitor extracellular nucleo-
tides, the mechanism underlying the apparent equipotency of
saturating ATP, UTP, and BzATP (Fig. 3B) is unclear sinceeach particular compound would activate the different
combinations of receptor units. On the other hand, if mostly
P2Y2 receptors are responsible for the nucleotide sensitivity of
taste cells, saturating ATP, UTP, and BzATP should elicit equal
cellular responses as they all are full P2Y2 agonists [11]. In
this case, taste cells should have exhibited simple one-site
dose–response curves for P2Y agonist/antagonist, as is the
case with recombinant receptors [11] and with the simulated
dependencies (Fig. 2C–F). However as shown below, the
intricacy of experimental dose–response curves implicates
Fig. 3. Nucleotide-induced Ca2+ transients in the cytoplasm of taste cells
monitored by Fura-2 fluorescence. (A, B) Saturating ATP, UTP, and BzATP
mobilize intracellular Ca2+ equipotently and more effectively than ADP and
UDP. The traces in panels A and B were recorded from two different taste buds.
(C) Response to the particular nucleotide at the saturating concentration
(indicated in the bottom) normalized to the response to 200 μM ATP. The data
are presented as mean±SE.
Table 1
Values of parameter for models with monomeric P2Y receptors
Receptors P2Y2+P2Y4 Parameter P2Y2+P2Y4+P2Y11
Agonist ATP BzATP ATP BzATP
Parameter Value (unit) Value (unit) Value (unit) Value (unit)
K2 15 (μM) 470 (μM) K2 13 (μM) 9 (μM)
K4 0.04 (μM) ND K4 0.04 (μM) ND
KI2 4 (μM) 4 (μM) K11 70 (μM) 1200 (μM)
KI4 1000 (μM) ND Ki2 2.7 (μM) 2.7 (μM)
δ2 10 10 Ki4 1000 (μM) ND
δ4 0.24 0 Ki11 12 (μM) 12 (μM)
δ2 3 0.8
δ4 0.24 0
δ11 7 9.2
In all cases, η1=0.00016, η2=0.069, η3=100, η4=0.0011, μ=0.015, ν=0.1,
θ=0.2; ND—not determined.
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taste cells.
3.2.1. Dose–response curves
As a function of ATP concentration, Ca2+ response normal-
ized to the control response to 10 μM ATP (∼EC70 concentra-
tion) (Fig. 4A, filled triangles) was fitted well over wide
concentration range of 10−2 to 103 μM with the one-site
equation (Fig. 4A, thick line):
RATP ¼ Rmax=ð1þ ðK0:5=½ATPÞnÞ ð5Þ
where Rmax=135%, K0.5=2.1 μM, n=0.81, and [ATP] being
expressed in μM. Such a dose–response curve could particularly
emerge if taste cells employ ATP receptors of a single type (e.g.
Fig. 2C). However, 10 μM suramin altered the shape of the ATP
dose–response curve (Fig. 4A, open triangles) rather than shifted
one (Fig. 2C, E), the phenomenon suggesting that ATP
responses were mediated by multiple P2Y receptors. Indeed,
the control ATP dose–response curve (Fig. 4A, filled triangles)
was also well fittable (not shown) with the two-site equation:
RATP=Rmax ¼ 0:1=ð1þ 0:03=½ATPÞ
þ 0:9=ð1þ ð3:5=½ATPÞ0:9Þ ð6Þ
with Rmax=135%. In the presence of 10 μM suramin, the ATP
concentrational dependence followed the equation (Fig. 4A, thin
line):
RATP=Rmax ¼ 0:1=ð1þ 0:3=½ATPÞ
þ 0:9=ð1þ ð7=½ATPÞ1:2Þ ð7Þ
with the same Rmax. The comparison of Eqs. (6) and (7)
demonstrates clearly that in main, the suramin effect is
analytically described as the 10-fold increase of EC50 for the
high affinity component from 0.03 to 0.3 μM, as should be the
case for the competitive antagonist (Fig. 2C, E). Thus, the
suramin effect (Fig. 4A) can qualitatively be attributed to
targeting two P2Y receptors with different affinities, assuming
that the high affinity receptors are much more sensitive tosuramin. This is consistent with the expression of the P2Y2 and
P2Y4 isoforms in taste cells [7].
For two P2Y receptors involved, a suramin inhibition–
concentration curve theoretically should follow a two-site
equation. Such a curve might provide separate evidence for
the presence of distinct functional nucleotide receptors in taste
cells. Although the suramin effect was more profound at small
ATP concentrations (Fig. 4A, open triangles), for cellular re-
sponses to 1 μM ATP or so, an experimental inhibitory curve
could not be generated with the necessary precision over a wide
range of inhibitor concentrations because of low response-to-
noise ratio. At 10 μM ATP that elicited responses with the
appropriate response-to-noise ratio (Fig. 4B), a small (∼10%,
based on Eqs. (6), (7)) contribution of ATP receptors with high
sensitivity to suramin to Ca2+ response could be expected.
Consistent with this inference is that both one-site and two-site
Fig. 4. Suramin effects on taste cell responses to ATP. (A) Normalized Ca2+ response as a function of ATP concentration in control (▾) and in the presence of 10 μM
suramin (▵). The thick and thin lines represent Eq. (5) and Eq. (7), respectively. The control ATP dose–response curve summarizes the data reported previously (10) and
recordings performed in the present work. It was scaled by normalizing the data to the magnitude of the control response to 10 μMATP (seeMaterials andmethods). The
data are presented as mean±SE (n=3–9). (B) Ca2+ transients elicited by 10 μM ATP in control and in the presence of 10 μM suramin. (C) Normalized ATP response
versus suramin concentration. Ca2+ transients recorded in the presence of suramin (Rsur) were normalized to the magnitude of the second control response to 10 μMATP
(R0). The data are expressed as mean±SE (n=3–6). The thick and thin lines correspond, respectively, to the equations Rsur/R0=1 / (1+([sur]/23)
0.8) and Rsur/R0=1.12/
(1+([sur]/0.5)0.9)+0.88/(1+([sur]/32)0.9), where [sur] is the suramin concentration expressed in μM.
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suramin inhibition curve generated at the 10 μM ATP
stimulation (Fig. 4C, circles) nearly with the same accuracy.
Although ATP and BzATP evoked apparently equal maximal
responses at saturating concentrations (Fig. 3B), these agonists
exhibited profoundly different dose–response curves. Unlike
the monotonic concentrational dependence obtained for ATP
(Fig. 4A), normalized Ca2+ response versus BzATP concentra-
tion (Fig. 5B, filled triangles) clearly required a biphasic fit with
the equation (Fig. 5B, thick line):
RBzATP=Rmax ¼ 0:4=ð1þ ð9:7=½BzATPÞ1:63Þ
þ 0:6=ð1þ ð347=½BzATPÞ2:5Þ
ð8Þ
where Rmax=131% and [BzATP] is expressed in μM. As is the
case with ATP, 10 μM suramin altered the shape of the BzATP
dose–response curve (Fig. 5, open triangles). A good approxi-
mation of the concentrational dependence generated in the
presence of suramin was achieved with the equation (Fig. 5B,
thin line):
RBzATP=Rmax ¼ 0:4=ð1þ ð25=½BzATPÞ1:1Þ
þ 0:6=ð1þ ð347=½BzATPÞ2:5Þ ð9Þ
with the same Rmax=131%. Thus, in line with the fitting analysis
of the ATP dose–response curves (Fig. 4A), suramin affected
solely the high affinity component in the BzATP dose–response
curves (Fig. 5B). This formal analytical approach suggests that:
(i) there are at least two distinct P2Y receptors in taste cells,which are particularly characterized by relatively high and low
affinities to BzATP; (ii) micromolar suramin inhibits effectively
the high affinity receptors, while it is an ineffective antagonist
for the low affinity receptors.
Given P2Yagonist/antagonist potencies accurately studied in
expression systems [31], the above inference is surprising
because it suggests that known P2Y receptors taken in any
combination cannot mediate, by their properties, the BzATP
dose–response curve in the presence of 10 μM suramin (Fig.
5B). Indeed, merely P2Y2 and P2Y11 are rendered active by
BzATP and both are effectively inhibited with micromolar
suramin. In search for a “missed” receptor, we carried out the
computer simulations of dose–response curves using different
sets of modeled P2Y receptors, all being coupled to PLC and
Ca2+ mobilization by the same G-protein.
3.3. Computations with different combinations of P2Y receptors
A number of parameters in the Eq. (1) were fixed over
computations described below: Ka=27 nM and Ha=1.8 [32],
KCG=400 nM and m=2 [12], [Ca
2+]0=70 nM [4], n=2 [33],
KC=500 nM, and KPMCA=700 nM, thus yielding ρ=Ka/
[Ca2+]0=0.38, λ=KPMCA/[Ca
2+]0=10, γ1=KC/[Ca
2+]0=7.1,
γ2=KCG/[Ca
2+]0=5.7. The other parameters were varied to fit
the experimental data. The concentrational dependencies for
ATP, BzATP, and suramin (Fig. 4A, filled triangles; Fig. 4C,
circles; Fig. 5B, filled triangles) were first approximated in-
dependently with theoretical curves calculated on the basis of
Eq. (1) and equations for agonist/antagonist binding (see below)
Fig. 5. Taste cell responses to BzATP. (A) Ca2+ transients elicited by 10 μMATP
(control response) and by 600 μMBzATP. (B) Normalized Ca2+ transient versus
BzATP concentration in control (▾) and in the presence of 10 μM suramin (▵).
BzATP responses were normalized to the magnitude of the second control
response. The data are presented as mean±SE (n=3–7). The thick and thin lines
represent Eq. (8) and Eq. (9), respectively.
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Thereafter, the parameters were varied in a vicinity of the found
values to achieve the best possible simultaneous approximation
of three experimental dependencies (the suramin inhibition
curve and ATP dose–response curves generated in control and in
the presence of 10 μM suramin), that is, to minimize the
following functional:
A ¼
X3
i¼1
X
j¼1
Ni
ðReij  RcijÞ2=Dij ð10Þ
where Ni is the number of experimental points in the particular
dose–response curve; Rij
e and Rij
c are the experimental and
calculated Ca2+ responses, respectively, at a given agonist/
antagonist concentration; Dij is the Rij
e variance. Further, BzATP
dose–response curves were simulated by varying solely
dissociation constants for BzATP-P2Y binding and efficacies
of G-protein activation. Note that this variant of the least square
method could not guarantee the best fit of the particular
concentrational dependence.
3.4. Monomeric receptors
In a number of computations, we checked the prediction of
the above analysis (Eqs. (6)–(9)) that monomeric “recombi-nant-like” P2Y receptors are unable to “mediate” taste cell
responses to BzATP (Fig. 5). Several P2Y combinations were
examined.
3.4.1. P2Y2+P2Y4
By analogy with Eqs. (2) and (3), the fractions of P2Y2 and
P2Y4 monomeric receptors bound to an agonist A in the
presence of a competitive antagonist and the fraction of
activated G-proteins are given by the equations:
F2 ¼ ð½A=K2Þ=ð1þ ½I =Ki2 þ ½A=K2Þ
F4 ¼ ð½A=K4Þ=ð1þ ½I =Ki4 þ ½A=K4Þ
FG ¼ ½G*=½GT  ¼ ðy2F2 þ y4F4Þ=ð1þ y2F2 þ y4F4Þ ð11Þ
where δ2 and δ4 characterize the efficacy of coupling of P2Y2
and P2Y4 receptors to G-protein activation, respectively. The
combination P2Y2+P2Y4 allowed for the satisfactory descrip-
tion of the suramin inhibitory curve (Fig. 6A, left panel, line)
and ATP dose–response curve (Fig. 6A, middle panel, thick
line). However, unlike the experimental findings (Fig. 4A),
suramin simply shifted theoretical dependence for ATP res-
ponses compared to control (Fig. 6A, middle panel, thin line).
For BzATP, a dose–response curve was simulated by taking
δ4=0 in Eq. (11), i.e. suggesting P2Y2 to solely mediate cellular
response. Expectedly, the model was unable to reproduce in
details the intricacy of the BzATP experimental dose response
curves generated in control and in the presence of 10 μM
suramin (Fig. 6A, right panel, thick and thin lines).3.4.2. P2Y2+P2Y4+P2Y1 or P2Y11
Given that our experimental findings (Fig. 5B) suggest
that two P2Y receptors mediate the responsiveness of taste
cells to BzATP, we simulated dose–response curves with
P2Y2+P2Y4+P2Y11 combination. For these P2Y receptors,
cellular responses were calculated by using equations:
F2 ¼ ð½A=K2Þ=ð1þ ½I =Ki22 þ ½A=K22Þ
F4 ¼ ð½A=K4Þ=ðð1þ ½I =Ki4 þ ½A=K4Þ
F11 ¼ ð½A=K11Þ=ðð1þ ½I =Ki11 þ ½A=K11Þ
FG ¼ ðy2F2 þ y4F4 þ y11F11Þ=ð1þ y2F2 þ y4F4 þ y11F11Þ
ð12Þ
Compared to P2Y2+P2Y4, the addition of P2Y11 to the
combination slightly improved the approximation of the
suramin inhibition curve (Fig. 6B, left panel), while the fit of
the ATP dose–response curves was virtually of the same
accuracy (Fig. 6B, middle panel). The presence of two
receptors, P2Y2 and P2Y11 responsive to BzATP allowed for
the better description of the control BzATP dose–response
curve (Fig. 6B, right panel, thick line). Nevertheless, the model
improperly simulated the effect of suramin, showing response
inhibition at high concentrations of BzATP (Fig. 6B, right panel,
thin line).
Fig. 6. Ca2+ response versus P2Yagonist or suramin concentration simulated for different combinations of monomeric P2Y receptors. A, B, left panels, experimental
(●) and computed (line) inhibition curves for suramin. Middle panels, experimental and computed Ca2+ response versus ATP concentration in control (▾ and thick
line) and in the presence of 10 μM suramin (▵ and thin line). Right panels, experimental and computed dose–response curves for BzATP in control (▾ and thick line)
and in the presence of 10 μM suramin (▵ and thin line). Theoretical dependencies were calculated for the sets P2Y2+P2Y4 (A) and P2Y2+P2Y4+P2Y11 (B). In all
cases, both experimental and computed responses were normalized to the magnitude of the control response (experimental or computed) to 10 μMATP. The theoretical
responses were calculated using the Mathcad software, Eq. (1) and Eq. (11) (A) or Eq. (12) (B) with the parameter sets presented in the Table 1.
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that is, F11, δ11, etc. in Eq. (12) were substituted for F1, δ1, etc.,
basically the same dependencies (Fig. 6B, left panel, and Fig.
6B, middle panel) were generated for suramin inhibition and for
ATP responses in control and in the presence of suramin (not
shown). Given that BzATP activates neither P2Y1 nor P2Y4,
BzATP responses were calculated with δ1=δ4=0, thus yielding
the curves identical to those in Fig. 6A, right panel, which were
generated with the set P2Y2+P2Y4.
3.5. Dimeric receptors
Even when computations were carried out with up to four
different monomeric recombinant-like P2Y receptors at widely
varied parameters in Eq. (1), our model was unable to
reproduce well all five experimental dependencies simulta-
neously (not shown). The proper simulation of the BzATP
responses (Fig. 5B) was the specific problem, which could not
be generally solved because of the high sensitivity of
monomeric P2Y2 and P2Y11, the only known P2Y receptors
for BzATP, to suramin. We tried to design P2Y receptors,
which could mediate taste cells responsiveness to BzATP at
least in theory. Note that the apparent cooperativity of BzATP
binding, as indicated by the exponents of 1.63 and 2.5 in Eq.
(8), pointed to the possibility that dimeric receptors might be
involved (see also Fig. 2E). We therefore hypothesized that in
the taste cell-specific environment, natural nucleotide recep-tors are liable to dimerization that may dramatically affect
their properties [19,34,35], compared to recombinant P2Y
receptors operative mostly as monomeric species in an
expression system. The “missed”, i.e. relatively insensitive to
suramin, receptor to BzATP may be produced by hetero-
dimerization of P2Y2 and P2Y4; the former endows the
heterodimer with the capability of being active in the presence
of BzATP, while P2Y4 imparts weak sensitivity to suramin to
the complex.
To evaluate whether the P2Y dimerization is of significance
for the purinergic signaling in taste cells, we simulated dose–
response curves for oligomeric receptors, including the com-
binations: P2Y22+P2Y44, P2Y2+P2Y24+P2Y4, and P2Y22+
P2Y24+P2Y44, where P2Y22 and P2Y44 are homodimers and
P2Y24 is the heterodimer composed of P2Y2 and P2Y4
receptors. Based on the properties of recombinant P2Y2 and
P2Y4 receptors [11], we postulated that: (i) ATP is a full agonist
for P2Y22, P2Y24, and P2Y44; (ii) the binding of two molecules
of suramin, a potent and very weak antagonist for recombinant
P2Y2 and P2Y4 receptors, to P2Y22, P2Y24, and P2Y44 inhibits
them strongly, moderately and very weakly, respectively; (iii)
BzATP is a full agonist for P2Y22 and P2Y24 but an antagonist
for P2Y44.
By extending Eq. (4), the fractions of activated P2Y22,
P2Y24, and P2Y44 receptors can be written as:
F22 ¼ ð½A=K22Þ2=ð1þ ½I =Ki22 þ ½A=K22Þ2
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 ð1þ ½I =Ki244 þ ½A=K244Þ
F44 ¼ ð½A=K44Þ2=ð1þ ½I =Ki44 þ ½A=K44Þ2 ð13Þ
where Kmm and Kimm are dissociation constants that characterize
agonist and antagonist binding to each nucleotide site in P2Y
homodimer. For the P2Y24 heterodimer, K242 and K244 (Ki242
and Ki244) characterize the binding of agonist (antagonist) to the
P2Y2 and P2Y4 binding sites, respectively.
3.5.1. P2Y2+P2Y4+P2Y24
In this case, the fraction of activated G proteins is given by
the expression:
FG ¼ ðy2F2 þ y24F24 þ y4F4Þ=ð1þ y2F2 þ y24F24 þ y4F4Þ
ð14Þ
with F2, F4, and F24 defined in Eqs. (12) and (13).
Compared to the P2Y2+P2Y4+P2Y11 combination (Fig.
6B), neither the approximation of the suramin inhibition
curve nor the fit of the control ATP and BzATP dose–
response curves were notably improved with the P2Y2+
P2Y4+P2Y24 set (Fig. 7A). Nevertheless, in the presence of
the P2Y24 dimer, the dependencies for ATP and BzATP
simulated with 10 μM suramin in the bath reproduced the
experimental curves better; rather than being originated by a
shift of the control dose–response curves, they exhibitedFig. 7. Cellular responses simulated with P2Y2/P2Y4 heterodimer. A, B, left panels
panels, experimental and computed Ca2+ response versus ATP concentration in contro
panels, experimental and computed dose–response curves for BzATP in control (▾ an
dependencies were calculated for the sets P2Y2+P2Y4+P2Y24 (A) and P2Y22+P2Y
(A) or Eq. (15) (B) with the parameter sets presented in the Table 2.more realistic shapes (Fig. 7A, middle and right panels, thin
lines).
3.5.2. P2Y22+P2Y24+P2Y44
For this combination
FG ¼ ðy22F22 þ y24F24 þ y44F44Þ
=ð1þ y22F22 þ y24F24 þ y44F44Þ
ð15Þ
This receptor set allowed for the best simultaneous fit of the
overall pharmacological data (Fig. 7B). Particularly, the BzATP
dose–response curves, both in control (Fig. 7, right panel, thick
line) and in the presence of 10 μM suramin (Fig. 7, right panel,
thin line), were adequately reproduced at the parameters shown
in Table 2. Note that the presence of the P2Y24 heterodimer was
absolutely necessary for the correct reproduction of the
experimental dependencies for BzATP responses (Fig. 7B,
right panel). For any combination of P2Y receptors without
P2Y24, the model was unable to generate the correct BzATP
dose–response curves. For example, with the P2Y22+P2Y44
combination, five simulated dose–response curves (not shown)
were only slightly different from those computed for P2Y2+
P2Y4 (Fig. 6A).4. Discussion
Based on the steady-state approximation of agonist binding–
Ca2+ response coupling, we elaborated here the analytical
approach to simulate dose response curves with different, experimental (●) and computed (line) inhibition curves for suramin. Middle
l (▾ and thick line) and in the presence of 10 μM suramin (▵ and thin line). Right
d thick line) and in the presence of 10 μM suramin (▵ and thin line). Theoretical
24+P2Y44 (B). Theoretical responses were calculated using Eq. (1), and Eq. (14)
Table 2
Values of parameter for models with P2Y2/P2Y4 heterodimer
Receptors P2Y2+P2Y4+P2Y24 Parameter P2Y22+P2Y24+P2Y44
Agonist ATP BzATP ATP BzATP
Parameter Value (unit) Value (unit) Value (unit) Value (unit)
K2 3 (μM) 13 (μM) K22 1.7 (μM) 5.1 (μM)
K4 0.04 (μM) ND K242 20 (μM) 450 (μM)
K242 5 (μM) 350 (μM) K244 40 (μM) 450 (μM)
K244 30 (μM) 350 (μM) K44 0.015 (μM) ND
KI2 1 (μM) 1 (μM) Ki22 2.1 (μM) 2.1 (μM)
Ki4 1000 (μM) ND Ki242 51 (μM) 51 (μM)
KI242 5 (μM) 5 (μM) Ki244 1000 (μM) 1000 (μM)
KI244 1000 (μM) 1000 (μM) Ki44 1000 (μM) 1000 (μM)
δ2 3 3 δ22 4.5 1
δ4 0.24 0 δ24 5.5 9
δ24 7 7 δ44 0.27 0
In all cases, η1=0.00016, η2=0.069, η3=100, η4=0.0011, μ=0.015, ν=0.1, θ=0.2.
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tion cascade. Compared to simple fitting with logistic equations
(Eqs. (5)–(9)), which provides no obvious link between
intracellular events and equation parameters, our methodology
provides a dipper interpretation of a pharmacological profile of
cellular responses, allowing for a clear demonstration of a role of
different signaling units in shaping dose–response curves,
especially taken in combination (Figs. 4–7). The important
instance is that with a high amplification cascade, only a small
fraction of activated receptors is required for generating the
saturated cellular response (Fig. 2B), thus compromising the
EC50 concentration as a relevant estimate on the true dissociation
constant of agonist–receptor binding. The expressions derived
here (Eq. (1) and Eqs. (11)–(15)) contain parameters, which
characterize separately, albeit without details, agonist–receptor
binding and the efficacy of its coupling to G-protein activation as
well as PLC-dependent IP3 production and transport units
involved in Ca2+ homeostasis. By varying these parameters and
solving the simple system of the algebraic equations (Eq. (1)),
one can judge on a relative contribution of a particular system
and its components, such as luminal Ca2+ or Ca2+–ATPase
extrusion rate, to the Ca2+ response magnitude.
The computations with receptors of a single type showed that
our model of Ca2+ signaling reproduces correctly such
phenomena as the partial agonism and antagonism (Fig. 2B–
E). In the present work, we postulated the negligible constitutive
activity of modeled P2Y receptors. For more complex kinetic
schemes of agonist–receptor–G-protein interaction suggesting
constitutive receptor activity (e.g. [14]), dose–response curves
characteristic of inverse agonists also could be simulated with
Eq. (1) (data not shown). Thus, our approach is instrumental for
modeling various binding events and their coupling to Ca2+
mobilization at least in terms of dose–response curves.
One of the specific aims of the present study was to probe into
our methodology with any cellular signaling system. As
necessary experimental basis, we used data on the responsive-
ness of taste cells to ATP and BzATP in the presence and in the
absence of suramin. These P2Y agonists and antagonist were
chosen based on the following: (i) Evidence exists that taste cellsexpress P2Y1, P2Y2, P2Y4 and P2Y6 receptors [7]; (ii)
Saturating ATP and UTP mobilized Ca2+ in taste cells with
nearly the same efficacy (Fig. 3), suggesting P2Y2 and P2Y4 to
be very likely involved; (iii) ATP is a full agonist for both P2Y2
and P2Y4 receptors; BzATP is a full P2Y2 agonist and a weak
P2Y4 antagonist; micromolar suramin is an effective P2Y2
antagonist but antagonizes agonist–P2Y4 binding negligibly.
Taken in combination, these compounds would allow for the
clear separation of P2Y2 and P2Y4 coupling to Ca
2+ responses.
For instance, if P2Y2 and P2Y4 receptors contributed compar-
ably to ATP responsiveness, BzATP should have been much less
effective than ATP, while suramin should have suppressed
BzATP responses effectively and shifted a BzATP dose–
response curve, most likely monotonic, without a change in its
shape. In fact, our findings (Figs. 4 and 5) did not meet our
expectations. Most contradictory was the biphasic BzATP dose–
response curve unexpectedly modified by suramin (Fig. 5B), the
result suggesting that BzATP stimulated two distinct receptors
with high and negligible sensitivities tomicromolar suramin. For
comparison, P2Y2 and P2Y11, the sole recombinant P2Y
receptors rendered active by BzATP, are effectively inhibited
by micromolar suramin, which is an ineffective antagonist for
P2Y4 and P2Y12 relative to any other P2Y isoform [31].
Consistently, numerous computer simulations of dose–response
curves clearly demonstrated that with monomeric recombinant-
like nucleotide receptors, our model was unable to adequately
reproduce BzATP dose–response curves (Figs. 5B and 6).
To address this problem, we speculated that the “unknown”
BzATP receptor with low sensitivity to suramin is the P2Y2/
P2Y4 heterodimer, which adopts some properties of the parental
monomers, namely, the effective coupling to G-proteins upon
BzATP binding and the low sensitivity to suramin. With such
nucleotide receptors, more realistic concentration dependencies
could be simulated. Particularly, when the homodimerization
of P2Y2 and P2Y4 was also assumed, the model yielded theo-
retical dose–response curves rather consistent with the overall
experimental findings (Fig. 7B). The clear message coming
from these simulations is that in taste cells, P2Y receptors may
operate mostly in the dimeric form. This prediction should be
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cells isolated from P2Y2- and/or P2Y4-null mice.
Our model provides the plausible explanation of the
apparent equipotency of saturating ATP and BzATP (Fig. 3).
Although the equipotency does not take place at the receptor
level, it is achievable at the downstream level of signaling,
because P2Y receptors are postulated to compete for the same
G-protein. For instance, when in the P2Y22+P2Y24+P2Y44
combination, P2Y44 is ineffective in the presence of BzATP,
P2Y22 and P2Y24 still may activate enough G-protein
molecules at the saturating BzATP concentration to mediate
the maximally possible Ca2+ response. In addition, the model
predicts correctly the absolute value of Ca2+ transients.
Experimentally, the averaged taste cell responses to saturating
ATP (200 μM) and BzATP (2 mM) were 256±34 nM (n=15)
and 245±21 nM (n=3), respectively, while for dimeric
receptors, the corresponding model responses were 275 nM
and 266 nM.
In conclusion, although the method described here was
developed by us for the analysis of taste cell responsiveness to
P2Y agonists/antagonists, it can be extended to interpret any
cellular responses generated with receptors coupled to the PLC-
mediated Ca2+ mobilization.
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Appendix
Here we used the following basic equation for the free
concentration of intracellular Ca2+, [Ca2+]:
ð1þ kBcytÞVcytd½Ca2þ=dt ¼ AJi ðA1Þ
where kBcyt and Vcyt are the Ca
2+ binding ratio characterizing
the buffering capacity [36] and the volume of the cytoplasm,
respectively; Ji is the value of Ca
2+ flux mediated by either
Ca2+ release (Jre), Ca
2+ entry (Jen), or Ca
2+ re-uptake/extrusion
(Jex). When an ATP response reaches the maximum, d[Ca
2+]/
dt=ΣJi =0, i.e. Jen+Jre+Jex=0. Given that in taste cells, IP3-
dependent Ca2+ release mostly determines the peak of ATP
responses (Fig. 1) with a small contribution of the store-
operated Ca2+ entry [5], the reasonable approximation is that the
cytosolic Ca2+ peak results basically from the re-distribution of
intracellular Ca2+ between the endoplasmic reticulum (ER).
This is equivalent to the following conservation condition:
ð1þ kBERÞVER½Ca2þER þ ð1þ kBcytÞVcyt½Ca2þ
¼ V ½Ca2þT ðA2Þ
where kBER is the Ca
2+ binding ratio for reticular Ca2+ buffer;
VER is the ER volume; [Ca
2+]ER and [Ca
2+]T are the con-
centration of free reticular Ca2+ and the total concentration of
exchangeable Ca2+; V is the cell volume. Here, both ER and
cytosolic Ca2+ buffers are of high concentration and low
affinity, the assumption that allows for the linear approximation,suggesting the direct proportion between concentrations of free
and bound Ca2+. In ATP-responsive taste cells, Na+/Ca2+
exchange, reticular Ca2+ pump, and mitochondria contribute
negligibly to the clearance of mobilized Ca2+, which is
predominantly mediated by the plasma membrane Ca2+-ATPase
(PMCA) [5]. Therefore at the moment of the Ca2+ peak, the
Ca2+ flux balance can be written as: J0+JER=JPMCA, where J0
is the value of Ca2+ influx at rest, and JER and JPMCA are values
of Ca2+ flux from ER and Ca2+ efflux mediated by PMCA,
respectively. We used the following approximations for the
fluxes:
J0 ¼ pPMð½Ca2þout  ½Ca2þÞ
JER ¼ ðpL þ pIP3Þð½Ca2þER  ½Ca2þÞ
JPMCA ¼ mex=ð1þ ðKPMCA=½Ca2þÞmÞ ðA3Þ
where [Ca2+]out is the concentration of external Ca
2+; PPM is the
Ca2+ permeability constant of the plasma membrane at rest; PL
and PIP3 are the permeability constants of the ER membrane
mediated by the leakage and IP3 receptors, respectively; νex and
KPMCA are the maximal rate of Ca
2+ extrusion and the apparent
dissociation constant of Ca2+–PMCA binding. The combina-
tion of Eqs. (A1) (A2) (A3) gives:
pPMð½Ca2þout  ½Ca2þÞ þ ðpL þ pIP3Þðr½Ca2þT
 ðrc þ 1Þ½Ca2þÞ ¼ mex=ð1þ ðKPMCA=½Ca2þÞmÞ
ðA4Þ
where r=V/(VER(1+ kBER)) and rc =Vcyt(1+ kBcyt)/(VER(1+
kBER)).
The activity of IP3 receptors is strongly modulated by free
cytosolic Ca2+, leading to a bell-like dependence of the steady-
state open probability on its concentration [32,37]:
pðCa2þÞ ¼ p0=ðð1þ ðKa=½Ca2þÞHaÞð1þ ð½Ca2þ=KiÞHiÞÞ
ðA5Þ
where P0 is the steady-state open probability at a given IP3
concentration and [Ca2+]=0, Ka and Ki are the apparent
affinities of the Ca2+ activating and Ca2+ inhibitory sites, Ha
and Hi are the corresponding Hill coefficients. Since for the
type 3 IP3 receptor (the predominant isoform expressed in
mammalian taste cells [38]), Ki≈40 μM at millimolar
intracellular ATP [32,39] and because the magnitude of
ATP-dependent Ca2+ transients typically did not exceed
300 nM, the Ca2+ inhibition term in the Eq. (A5) can be
omitted in our case. Ignoring the intrinsic inactivation of IP3
receptors [40] and taking into account that in IP3 receptors of
the type 3, the IP3 and Ca
2+ activating binding sites operate
independently [39], it can be written for the IP3-dependent
permeability constant:
pIP3 ¼ pmax½IP3n=ð½IP3n0:5 þ ½IP3nÞð1þ ðKa=½Ca2þÞHaÞ
ðA6Þ
where [IP3]0.5 is the half-activation concentration of IP3.
Taking into account that [Ca2+]out≫ [Ca2+], the final equation
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centration is:
ðrc þ 1Þðr½Ca2þT=ðrc þ 1Þ  ½Ca2þpÞ
 ðpL þ pmax=ðð1þ ð½IP30:5=½IP3ÞnÞ
 ð1þ ðKa=½Ca2þpÞHaÞÞÞ þ pPM½Ca2þout
¼ mex=ð1þ ðKPMCA=½Ca2þpÞmÞ ðA7Þ
A.1. PLC activation and IP3 production
The IP3 production due to PIP2 hydrolysis by activated PLC*
and its degradation by kinases to other inositolphosphates (IPs)
were described as follows:
PIP2 þ PLC*fPIP2PLC* Z PLC* þ DAGþ IP3
IP3Z IPS
The corresponding equation
d½IP3dt ¼ mIP3  kd½IP3 ðA8Þ
has the following solution
½IP3 ¼ expðkdtÞð½IP30 þ
Z t
0
mIP3expðkdsÞdsÞ ðA9Þ
where νIP3 is the rate of PLC-mediated IP3 production, kd is the
rate constant of IP3 degradation, and [IP3]0 is the IP3
concentration at t=0.
For full activation, all types of PLC require the presence of Ca2+
[41]. In the recentmodel of P2Y2-mediatedCa
2+ signaling [12], the
following expression has been deduced for the rate of PIP2
hydrolysis, i.e. IP3 production, by Ca
2+/G-protein-simulated PLC:
mIP3 ¼ aG*½PIP2½Ca2þ=ðKC þ ½Ca2þÞ ðA10Þ
where α is a constant; KC is the apparent dissociation constant of
Ca2+-PLC binding; G* is the concentration of active GTP-protein
species, i.e. GTP-bound α-subunits of the Gq-protein in [12].
Given that G-protein independent Ca2+ dependent PLC also
operates in taste cells (Y.E.Yatzenko, S.S.Kolesnikov, unpublished
observations), we extended Eq. (A10) to the following equation
using the formalism as in [12]:
mIP3 ¼ aG*½PIP2½Ca2þ=ðKCG þ ½Ca2þÞ
þ h½PIP2½Ca2þ=ðKC þ ½Ca2þÞ ðA11Þ
where β is constant; KCG and KC are the apparent dissociation
constants of Ca2+-PLC binding for G-protein dependent and G-
protein independent PLC isoforms, respectively; the others are as in
Eq. (A10). The combination of Eqs. (A9) and (A11) results in the
expression for the IP3 concentration at the moment when Ca
2+
peaks (tp):
½IP3p ¼ expðkdtpÞð½IP30
þ
Z tp
0
½PIP2½Ca2þðaG*=ðKCG þ ½Ca2þÞ
þ h=ðKC þ ½Ca2þÞexpðkdtÞdtÞÞ ðA12ÞBased on the mean value theorem for a monotonic function
G(x) [42]:
Z b
a
GðxÞFðxÞdx ¼ GðaÞ
Z f
a
FðxÞdxþ GðbÞ
Z b
f
FðxÞdx ðabfbbÞ
ðA13Þ
and positing that [PIP2] declines monotonically at 0b tb tp and
that G*=0 in a non-stimulated cell, it can be deduced from Eqs.
(A12) and (A13):
½IP3p=½IP30:5 ¼ Aþ m½Ca2þp=ðKC þ ½Ca2þpÞ
þ uFG½Ca2þp=ðKCG þ ½Ca2þpÞ ðA14Þ
where μ=exp(−kdtp)([IP3]0/[IP3]0.5+βI1[Ca2+]r/([IP3]0.5(KC+
[Ca2+]r))); ν=βI2 exp(−kdtp)/[IP3]0.5; θ=αGTI2 exp(−kdtp)/
[IP3]0.5; I1 ¼
R t1
0 ½PIP2expðkdtÞdt and I2 ¼
R tp
t1
½PIP2expðkdtÞdt
with 0b t1b tp; FG=G*/GT is the fraction of activated G-
proteins; GT is the total concentration of G-proteins; [Ca
2+]r is
the resting Ca2+ concentration. In general, μ, ν, and θ may vary
with stimulus intensity as both tp and [PIP2] kinetics may
depend on FG. However for simplicity, they were taken as
constants in the computations performed here. By introducing
the new variables x=[Ca2+]p/[Ca
2+]r and y=[IP3]p/[IP3]0.5, the
following system can be derived from Eqs. (A7) and (A14):
g1 þ g2ðg3  xÞðg4 þ ynxHa=ðð1þ ynÞðqHa þ xHaÞÞ
¼ xm=ðkm þ xmÞ
y ¼ Aþ mx=ðg1 þ xÞ þ uFGx=ðg2 þ xÞ ðA15Þ
where η1=PPM[Ca
2+]out/νex, η2= (rc+1)[Ca
2+]rPmax/νex, η3=
(r/(rc + 1))([Ca
2+]T/[Ca
2+]r), η4 = PL/Pmax, ρ=Ka/[Ca
2+]r,
λ=KPMCA/[Ca
2+]r, γ1=KC/[Ca
2+]r, γ2=KCG/[Ca
2+]r. Given
that at rest, FG=0, y=y0, and x=x0=1, the parameters in
Eq. (A14) are not completely independent as they should
adhere to the system:
g1 þ g2ðg3  1Þðg4 þ yn0=ðð1þ yn0ÞðqHa þ 1ÞÞ ¼ 1=ðkm þ 1Þ
y0 ¼ Aþ m=ðg1 þ 1Þ ðA16Þ
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